DX Cover Logo2

 

DxCover

DXCover is a clinical stage liquid biopsy company developing tests for the early detection of multiple cancers, when treatment has a better chance to impact outcomes. The company has pioneered the early detection and identification of cancer employing infrared spectroscopy of circulating paDX Cover Image-omic biomarkers. The company has generated compelling clinical data with high accuracy detection of Stage I and Stage II cancers. Dxcover is based in Scotland, United Kingdom and is establishing operations in the USA.

 

 

https://www.dxcover.com/

ProductEarly Stage Cancer Diagnosis
SectorMedical
Aim of fundingDevelopment
HMRC Advanced Assurance receivedYes
Envisaged investor exit4-5 Years
Targeted return4 x